Difference between revisions of "Epidermal growth factor receptor inhibitors"
Jump to navigation
Jump to search
(+TKI) |
m |
||
| Line 6: | Line 6: | ||
Note: | Note: | ||
*Both ''gefitinib'' and ''erlotinib'' are also classified as ''tyrosine kinase inhibitors'' ( | *Both ''gefitinib'' and ''erlotinib'' are also classified as ''[[tyrosine kinase inhibitors]]'' (TKIs). | ||
==Use== | ==Use== | ||
Revision as of 16:10, 29 March 2012
Epidermal growth factor receptor inhibitors, abbreviated EGFR inhibitors, is a class of drugs that blocks the EGF receptor.
Drugs
Note:
- Both gefitinib and erlotinib are also classified as tyrosine kinase inhibitors (TKIs).